Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 May 11:11:11.
doi: 10.1186/1471-2482-11-11.

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study

Daniel J Lips  1 , Boukje Koebrugge, Gerrit Jan Liefers, Johannes C van de Linden, Vincent T H B M Smit, Hans F M Pruijt, Hein Putter, Cornelis J H van de Velde, Koop Bosscha
Affiliations
Randomized Controlled Trial

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study

Daniel J Lips et al. BMC Surg. .

Abstract

Background: The presence of lymph node metastases remains the most reliable prognostic predictor and the gold indicator for adjuvant treatment in colon cancer (CC). In spite of a potentially curative resection, 20 to 30% of CC patients testing negative for lymph node metastases (i.e. pN0) will subsequently develop locoregional and/or systemic metastases within 5 years. The presence of occult nodal isolated tumor cells (ITCs) and/or micrometastases (MMs) at the time of resection predisposes CC patients to high risk for disease recurrence. These pN0(micro+) patients harbouring occult micrometastases may benefit from adjuvant treatment. The purpose of the present study is to delineate the subset of pN0 patients with micrometastases (pN0(micro+)) and evaluate the benefits from adjuvant chemotherapy in pN0(micro+) CC patients.

Methods/design: EnRoute+ is an open label, multicenter, randomized controlled clinical trial. All CC patients (age above 18 years) without synchronous locoregional lymph node and/or systemic metastases (clinical stage I-II disease) and operated upon with curative intent are eligible for inclusion. All resected specimens of patients are subject to an ex vivo sentinel lymph node mapping procedure (SLNM) following curative resection. The investigation for micrometastases in pN0 patients is done by extended serial sectioning and immunohistochemistry for pan-cytokeratin in sentinel lymph nodes which are tumour negative upon standard pathological examination. Patients with ITC/MM-positive sentinel lymph nodes (pN0(micro+)) are randomized for adjuvant chemotherapy following the CAPOX treatment scheme or observation. The primary endpoint is 3-year disease free survival (DFS).

Discussion: The EnRoute+ study is designed to improve prognosis in high-risk stage I/II pN0(micro+) CC patients by reducing disease recurrence by adjuvant chemotherapy.

Trial registration: ClinicalTrials.gov: NCT01097265.

PubMed Disclaimer

Figures

Figure 1
Figure 1
EnRoute+ study according to CONSORT
Figure 2
Figure 2
EnRoute+ flow chart
Figure 3
Figure 3
EnRoute+ follow up. OCV: outpatient clinic visit. CEA: carcinoma embryonic antigen abd. US: abdominal ultrasonography.
See this image and copyright information in PMC

References

    1. van Steenbergen LN, Lemmens VE, Louwman MJ, Straathof JW, Coebergh JW. Increasing incidence and decreasing mortality of colorectal cancer due to marked cohort effects in southern Netherlands. Eur J Cancer Prev. 2009;18:145–152. doi: 10.1097/CEJ.0b013e32831362e7. - DOI - PubMed
    1. Association of Comprehensive Cancer Centres. Guideline 'Colon cancer'. 2008. http://www.oncoline.nl Ref Type: Electronic Citation.
    1. Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn. 2007;9:563–571. doi: 10.2353/jmoldx.2007.070032. - DOI - PMC - PubMed
    1. Iddings D, Ahmad A, Elashoff D, Bilchik A. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol. 2006;13:1386–1392. doi: 10.1245/s10434-006-9120-y. - DOI - PubMed
    1. Bilchik A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M. et al.Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg. 2010;252:467–474. - PMC - PubMed

Publication types

Associated data